Muhammad Beg, M.D. Titles and Appointments Associate Professor Endowed Title Dedman Family Scholar in Clinical Care Schools Medical School Departments Internal Medicine Biography Dr. M. Shaalan Beg joined the Division of Hematology/Medical Oncology specializing in cancers of the gastrointestinal tract. After receiving his medical training at the Aga Khan University in Karachi, Pakistan, he proceeded to complete his Internal Medicine residency and Hematology/Medical Oncology fellowship at the University of Cincinnati. Dr. Beg’s clinical and research focus is on early-phase drug development and clinical trials for gastrointestinal cancers. He is an active member of the GI Cancers Disease Oriented Team and believes in true multidisciplinary care of his patients. Education Undergraduate Aga Khan University Medical Co (2003) Research Interest Cancers of the gastrointestinal tract Decentralized clinical trials Digital Health Early phase drug development, Phase I/II clinical trials Experimental therapeutics Publications Featured Publications Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline. Gordan JD, Kennedy EB, Abou-Alfa GK, Beg MS, Brower ST, Gade TP, Goff L, Gupta S, Guy J, Harris WP, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb AO, Kelley RK, Knox JJ, Kortmansky J, Leaf A, Remak WM, Shroff RT, Sohal DPS, Taddei TH, Venepalli NK, Wilson A, Zhu AX, Rose MG, J Clin Oncol 2020 Dec 38 36 4317-4345 Targeting TAM to Tame Pancreatic Cancer. von Itzstein MS, Burke MC, Brekken RA, Aguilera TA, Zeh HJ, Beg MS, Target Oncol 2020 Sep Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma. Ahmad SA, Duong M, Sohal DPS, Gandhi NS, Beg MS, Wang-Gillam A, Wade JL, Chiorean EG, Guthrie KA, Lowy AM, Philip PA, Hochster HS, Ann Surg 2020 Jul Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, Brenner AJ, Park K, Lee JL, Kim TY, Shin S, Becerra CR, Falchook G, Stoudemire J, Martin D, Kelnar K, Peltier H, Bonato V, Bader AG, Smith S, Kim S, O'Neill V, Beg MS, Br J Cancer 2020 May 122 11 1630-1637 Ascites, or Fluid in the Belly, in Patients With Cancer. Gupta A, Sedhom R, Beg MS, JAMA Oncol 2020 02 6 2 308 Phase 1 study of ARQ 761, a ?-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis. Gerber DE, Beg MS, Fattah F, Frankel AE, Fatunde O, Arriaga Y, Dowell JE, Bisen A, Leff RD, Meek CC, Putnam WC, Kallem RR, Subramaniyan I, Dong Y, Bolluyt J, Sarode V, Luo X, Xie Y, Schwartz B, Boothman DA Br. J. Cancer 2018 Oct 119 8 928-936 Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data. Komrokji RS, Al Ali NH, Beg MS, Safa MM, Rollison D, Kharfan-Dabaja M, Bello C, Cultrera J, Sokol L, Pinilla-Ibarz J, Sotomayor EM Clin Lymphoma Myeloma Leuk 2011 Jun 11 3 257-60 Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry. Beg MS, Navaneethan U, Atiq M, Komrokji R, Safa M Am. J. Clin. Oncol. 2009 Jun 32 3 286-90 Oxaliplatin-induced immune mediated thrombocytopenia. Beg MS, Komrokji RS, Ahmed K, Safa MM Cancer Chemother. Pharmacol. 2008 Oct 62 5 925-7 Self-reported Reasons and Patterns of Noninsurance Among Cancer Survivors Before and After Implementation of the Affordable Care Act, 2000-2017. Sanford NN, Lam MB, Butler SS, Ahn C, Beg MS, Aizer AA, Mahal BA, JAMA Oncol 2019 May e191973 Results 1-10 of 48 1 2 3 4 5 Next Last Honors & Awards ASCO Leadership Development Program (2019) Principal Investigator, NCI Experimental Therapeutics Clinical Trials Network (ETCTN) UM1 Award (2019) ASCO Quality Training Program (2017) Chair, Pancreatic-Hepatobiliary Working Group, GI Cancer Core Committee, ECOG/ACRIN (2017) Pancreatic Cancer Task Force, GI Cancer Steering Committee, National Cancer Institute (2017) D Magazine, Best Doctors (2016) Resident Teacher AwardUniversity of Cincinnati Professional Associations/Affiliations American Society of Clinical Oncology (2008) ECOG/ACRIN Research Group (2014)
